Abstract
Radiomics is a fast-growing research area based on converting standard-of-care imaging into quantitative minable data and building subsequent predictive models to personalize treatment. Radiomics has been proposed as a study objective in clinical trial concepts and a potential biomarker for stratifying patients across interventional treatment arms. In recognizing the growing importance of radiomics in oncology, a group of medical physicists and clinicians from NRG Oncology reviewed the current status of the field and identified critical issues, providing a general assessment and early recommendations for incorporation in oncology studies.
Original language | English |
---|---|
Pages (from-to) | 302-315 |
Number of pages | 14 |
Journal | International Journal of Radiation Oncology Biology Physics |
Volume | 104 |
Issue number | 2 |
DOIs | |
State | Published - Jun 1 2019 |